Consuming too much salt is a staple concern of modern public health, primarily due to its well-documented role in driving hypertension and cardiovascular disease. However, emerging scientific evidence suggests that the impact of a high-salt diet (HSD) extends far beyond blood pressure, potentially compromising memory, cognitive processing, and emotional well-being. As global diets increasingly rely on processed foods high in sodium, researchers are urgently seeking interventions to mitigate these systemic risks. A groundbreaking study from Japan has identified a potential solution in LPC70, a specialized compound derived from soy, which may protect both the kidneys and the brain from the detrimental effects of excessive salt intake.
The research, led by a collaborative team from Fujita Health University and Tsuji Oil Mills Co., Ltd., sheds new light on the molecular mechanisms that govern salt-induced damage. Published on July 1, 2026, in volume 197 of the journal Neurochemistry International, the study provides a detailed look at how LPC70 interacts with the body’s internal signaling systems, offering a promising avenue for nutritional therapy.
How a Soy Compound May Counter the Effects of Excess Salt
At the heart of the research are prostaglandins—signaling molecules synthesized from arachidonic acid, a type of fatty acid. Prostaglandins function similarly to local hormones, exerting influence over a vast array of physiological processes. In the cardiovascular system, they act as critical regulators of blood pressure, managing the complex interplay between the constriction and dilation of blood vessels.
The role of prostaglandins within the brain, however, is significantly more nuanced. These molecules can interact with various receptors to either protect nerve cells from injury or, conversely, contribute to harmful inflammatory processes. Depending on the pathway activated, this signaling can have profound consequences for memory retention, executive thinking, and emotional regulation.
LPC70 is a form of soy lysolecithin, specifically engineered so that lysophosphatidylcholine (LPC) accounts for more than 70% of the total phospholipids. While previous preliminary experiments suggested that LPC70 could alleviate both salt-related hypertension and cognitive impairment, the precise physiological mechanism remained elusive. A research team led by Professor Akihiro Mouri and Dr. Hisayoshi Kubota, in collaboration with Dr. Kazuhiro Kagotani of the Tsuji Health and Beauty Science Laboratory at Mie University, set out to map how this compound influences prostaglandin signaling pathways in mice subjected to a high-salt diet.
Dr. Kubota, the study’s lead author, spearheaded the experiments, which involved rigorous monitoring of blood pressure, behavioral assessments, and molecular analysis of prostaglandin activity. By examining the specific organ systems most affected by salt—the kidneys and the brain—the team aimed to clarify why LPC70 produces distinct, protective effects in different parts of the body.
"We wanted to understand the role of LPC70 in coordinating changes in prostaglandin signaling across organ systems," Professor Mouri explained. The study was born from a long-standing partnership with Tsuji Oil Mills Co., Ltd., a firm specializing in the development of naturally derived, bioactive food ingredients. The researchers believe that by understanding how the body balances these signals, they can develop targeted dietary interventions to counteract the risks associated with high sodium intake.
Soy Compound Improves Blood Pressure and Memory in Mice
To establish a baseline for the study, the researchers placed mice on a high-salt diet. As expected, the physiological toll was significant. Beyond the predictable rise in blood pressure, the mice exhibited marked behavioral changes that suggested cognitive and social decline. These animals became noticeably less interactive with their peers and struggled to recognize objects they had previously encountered, signaling a failure in memory formation.
Interestingly, the high-salt diet did not result in generalized physical impairment; the mice showed no significant changes in their overall movement patterns or general anxiety levels. This selective disruption indicates that excessive sodium may target specific neural circuits involved in complex social and cognitive tasks rather than causing a global breakdown in behavior.
When the researchers introduced LPC70 into the diets of these mice, the results were striking. The supplement effectively lowered blood pressure and restored performance in tests of object recognition and social interaction. These improvements provided the impetus for the team to investigate the underlying molecular changes occurring within the kidneys and the prefrontal cortex—a brain region central to memory and social behavior.
Different Protective Effects in the Kidneys and Brain
The team discovered that the protective effects of LPC70 are highly specific, adapting to the biological requirements of each organ. In the kidneys, a high-salt diet was found to increase the expression of cyclooxygenase-2 (COX-2) and the PGE2 receptor EP3. These two components are known drivers of hypertension; by suppressing these signals, LPC70 helps the kidneys return to a more stable state, thereby assisting in the regulation of blood pressure.
In the prefrontal cortex, the response to salt was entirely different. Excess salt led to a decrease in the expression of the PGD2 receptor DP1, a receptor linked to anti-inflammatory and protective signaling within the brain. When LPC70 was administered, it restored the expression of the DP1 receptor. Crucially, the compound did not affect the DP2 receptor, which is often associated with harmful inflammatory processes in nerve cells.
This selective regulation is a significant finding. It suggests that LPC70 does not function as a blunt instrument that merely suppresses all prostaglandin activity. Instead, it appears to selectively enhance protective pathways while leaving potentially deleterious or unrelated pathways untouched. This precision may explain why the mice showed cognitive recovery without experiencing negative systemic side effects.
A Surprising Change in Chemical Signaling
Perhaps the most unexpected discovery involved the metabolism of arachidonic acid. Under normal conditions, the body uses this fatty acid to produce various prostaglandins. In the mice on a high-salt diet, researchers observed a decrease in the levels of circulating arachidonic acid. Paradoxically, even with lower levels of this precursor, the administration of LPC70 actually increased the levels of PGE2 and PGD2.
The researchers hypothesize that LPC70 improves the efficiency with which the body utilizes available arachidonic acid to synthesize prostaglandins in high-salt environments. This ability to optimize internal chemical resources suggests that the compound acts as a metabolic facilitator, allowing the body to maintain homeostasis even under the stress of a high-sodium intake. By coordinating these organ-specific responses, LPC70 serves as a multifaceted guardian against the systemic damage caused by excess salt.
Could Soy-Based Ingredients Help Protect Against Excess Salt?
The implications of this research are substantial, particularly for a global population that consumes far more salt than is recommended by health organizations. If these findings can be replicated in humans, LPC70 could transition from a laboratory compound to a valuable functional food ingredient, offering a preventive measure against hypertension-related cognitive decline.
However, the researchers remain cautious, noting that while the results in mice are highly encouraging, they are not yet a direct roadmap for human health. Further clinical studies are required to confirm whether the protective effects observed in mice—specifically the modulation of prostaglandin receptors—translate to human physiology.
"Our study elucidates LPC70’s role in prostaglandin signaling, laying the groundwork for future clinical research and dietary interventions aimed at reducing hypertension-related cognitive decline and promoting healthy aging globally," Professor Mouri concluded.
The study was supported by a variety of prestigious institutions, including the Japan Society for the Promotion of Science, the Fujita Mind-Brain Research & Innovation Center for Drug Generation (Fujita Mind-BRIDGe), and the Japan Science and Technology Agency’s FOREST Program. Additional funding was provided by the Takeda Science Foundation and the Smoking Research Foundation, reflecting the broad interest in finding dietary solutions to complex chronic health issues. As science continues to uncover the link between our diets and our long-term brain health, the potential for soy-derived compounds to protect the aging brain remains a significant and exciting frontier in nutritional medicine.
